The present invention relates to a new modus and a new regimen of administration of divalent iron for therapy of hyposideremia, at the same time reducing toxic side effects, and new formulations containing divalent iron compounds adapted to release iron for intrabuccal absorption, preferably by sublingual absorption, that achieve these objects.